Workflow
JanOne (JAN)
icon
Search documents
ALT5 Sigma, a wholly-owned subsidiary of JanOne, Launches ALT5 Settlement Platform aimed at the untapped $27.3 Billion Global Digital Content Creation Market
Prnewswire· 2024-06-11 12:30
Core Insights - JanOne Inc. has launched the ALT5 Settlement Platform to address the needs of the Global Digital Content Creation Market, which is currently valued at $27.3 billion and projected to grow at a rate of 13.3% from 2023 to 2030 [3][4]. Company Overview - JanOne Inc. is a multidisciplinary organization listed on Nasdaq, focusing on healthcare and fintech, and is part of the Russell Microcap Index [8]. - ALT5 Sigma, a wholly-owned subsidiary of JanOne, specializes in blockchain-powered technologies for digital financial transactions [9]. Product Launch and Features - The ALT5 Settlement Platform allows digital platforms to pay content creators instantly in their preferred cryptocurrencies, including Bitcoin, Ether, USDT, and USDC, enhancing efficiency and reducing costs associated with payment settlements [2][3]. - The platform supports automatic loading of prepaid VISA cards for content creators, enabling them to shop globally at 130 million merchant locations or withdraw funds from 14,500 financial institutions [2]. Market Potential - The Global Digital Content Creation Market is characterized by over 200 million content creators, many of whom earn less than $100,000 annually, highlighting the need for efficient payment solutions [3]. - Traditional banking methods for smaller payments are time-consuming and costly, which the ALT5 Settlement Platform aims to resolve [3]. Initial Performance - The ALT5 Settlement Platform began as a pilot project in September 2023, with an initial settlement volume of $1 million, which has since increased to over $7 million per month [4]. Transaction Volume - ALT5 has processed over $1.2 billion in cryptocurrency transactions in 2023, indicating strong market engagement and operational capacity [5].
JanOne Inc. added to the Russell Microcap® Index
Prnewswire· 2024-06-03 16:05
Core Insights - JanOne Inc. has been added to the Russell Microcap® Index, marking a significant milestone for the company [1][3] - The Russell Microcap® Index includes 1,000 securities and is widely utilized by investment managers and institutional investors [2] - The addition to the index is expected to enhance visibility for JanOne, especially following its recent acquisition of ALT 5 Sigma [3] Company Overview - JanOne is a multidisciplinary organization listed on Nasdaq, focusing on healthcare and fintech [6] - The company is developing solutions aimed at addressing the opioid crisis and has promising drugs in its clinical trial pipeline [6] - JanOne's subsidiary, ALT 5, offers blockchain-powered technologies for trading, clearing, settlement, payment, and custodianship of digital instruments [7] ALT 5 Sigma Overview - ALT 5 Sigma, launched in 2018, provides next-generation blockchain technologies and has two main platforms: ALT 5 Pay and ALT 5 Prime [4][5] - ALT 5 Pay is a cryptocurrency payment gateway that allows merchants to accept and make cryptocurrency payments, with options for automatic conversion to fiat currencies [4] - ALT 5 Prime is an electronic trading platform for buying and selling digital assets, accessible via a mobile application and other platforms [5]
ALT 5 Sigma, a wholly-owned subsidiary of JanOne to Present at the iFX Expo, the World's largest online trading conference and tradeshow
Prnewswire· 2024-05-28 06:00
LAS VEGAS, May 28, 2024 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN) a multidisciplinary organization with a focus on healthcare and fintech, announced today that its Fintech subsidiary, ALT 5 Sigma, will be presenting at the iFX Expo, the World's largest online trading conference and tradeshow held on June 18 until June 20 in Limassol, Cyprus. https://cyprus2024.ifxexpo.com/ The iFX Expo brings together thousands of C-Level Executives and Industry Peers from 120 countries. The Online Trading Platform Market w ...
JanOne Closes Acquisition of ALT 5 Sigma Inc., a Leading Next Generation Blockchain Fintech
prnewswire.com· 2024-05-16 20:00
About JanOne Inc. — JanOne is a unique Nasdaq-listed company offering innovative, actionable solutions intended to help end the opioid crisis. JanOne is dedicated to funding resources toward innovation, technology, and education to find a key resolution to the national opioid epidemic, which is one of the deadliest and most widespread in the nation's history. Its drugs in the clinical trial pipeline have shown promise for their innovative targeting of the causes of pain as a strategic option for physicians ...
JanOne to Acquire ALT 5 Sigma Inc., a Leading Next Generation Blockchain Financial Technology Provider
Prnewswire· 2024-05-10 20:10
ALT 5's transactional processing volume exceeded $1.1 billion in calendar 2023, and over $450 million in Q1 2024LAS VEGAS, May 10, 2024 /PRNewswire/ -- JanOne Inc. (Nasdaq: JAN) announced today that it has executed a Definitive Agreement to acquire blockchain financial technology provider, ALT 5 Sigma Inc., a Delaware corporation, and each of its wholly-owned subsidiaries. The transaction is anticipated to close the week of May 13th, 2024 and is subject to customary closing conditions and regulatory require ...
JanOne (JAN) - 2023 Q4 - Annual Report
2024-04-08 20:21
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 For the fiscal year ended December 30, 2023 or o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File No. 000-19621 JANONE INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 325 E. Warm Springs Road, Las Vegas, Nevada 89119 (Address of principal executive offic ...
JanOne (JAN) - 2023 Q3 - Quarterly Report
2023-11-14 21:26
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2023 or o Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File No. 0-19621 JANONE INC. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation or organization) 325 E. Warm S ...
JanOne (JAN) - 2022 Q4 - Annual Report
2023-04-17 20:50
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2022 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File No. 000-19621 JANONE INC. (Exact name of registrant as specified in its charter) (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: 702- ...
JanOne (JAN) - 2021 Q4 - Annual Report
2021-03-30 21:01
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | | | For the fiscal year ended January 2, 2021 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File No. 000-19621 JANONE INC. (Exact name of registrant as specified in its charter) Nevada 41-1454591 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 325 E. Warm Springs Road, Las Vegas, Nevada 89119 (Address of principal e ...
JanOne Inc. (JAN) CEO Tony Isaac on Drug Candidate JAN101 - Telebriefing and Corporate Update Call Transcript
2020-08-26 01:38
JanOne Inc. (NASDAQ:JAN) Telebriefing and Corporate Update Call August 25, 2020 4:15 PM ET Corporate Participants Tony Isaac - Chief Executive Officer Tony Giordano - Chief Scientific Officer Amol Soin - Chief Medical Officer Conference Call Participants Jeremy Roe - Integra Robert Carlson - Janney Montgomery Scott Operator Good afternoon everyone and thank you for joining us for the JanOne Telebriefing and Corporate Update Call. Tony Isaac CEO, Tony Giordano, PhD, Chief Scientific Officer and Amol Soin, MD ...